1 Patent
- US122584092025Method of Assessing the Efficacy of a Test Agent for Modulating Programmed Death 1 (PD-1) Signaling by Using Anti-phosphotyrosinylated PD-1 Monoclonal Antibodies
President And Fellows Of Harvard College
0 cites
President And Fellows Of Harvard College